We caught some personnel updates and other news from public and private New England companies developing drugs, medical devices, and diagnostics technology. —Woburn, MA-based Pathogenetix, the diagnostics and biodefense company formerly known as U.S. Genomics, raised $4 million of a targeted $9.5 million equity financing. —Beacon Endoscopic, a Newton, MA-based startup that’s developed a fine … Continue reading “Celgene Pumps Up Acceleron, On-Q-ity CEO Goes to Roche Unit, MSMB Eyes Amag, & More Boston-Area Life Sciences News”
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
M/A-COM Seeks $230M IPO
Lowell, MA-based M/A-COM Technology Solutions indicated in an SEC filing that it seeks to raise $230 million through an initial public offering. The company, which makes wireless chips, is owned by the semiconductor-focused private equity fund GaAs Labs, whose owner John Ocampo bought the firm for around $90 million in 2009. Lead underwriters for the … Continue reading “M/A-COM Seeks $230M IPO”
Help Scout Looks To Boost Collaboration For Businesses’ “Catch-All” E-Mail Inboxes
It’s probably reassuring for online shoppers and the like to know that the generic-sounding address they e-mail—-usually dubbed something like help, service, or contact @xyz.com—is actually manned by people and not robots. And TechStars Boston 2011 graduate Help Scout is looking to make life easier for the humans that are responding to those queries. “We … Continue reading “Help Scout Looks To Boost Collaboration For Businesses’ “Catch-All” E-Mail Inboxes”
Carbonite Eyes $122M IPO, Plexxi Nabs $20M, Ambient Hits Nasdaq, & More Boston-Area Deals News
Plenty of New England startups across IT and biotech sectors inked investments from area venture capitalists this week. —Interactions, a speech and customer service technology developer of Franklin, MA, nabbed $12 million in a deal led by Sigma Partners. Interactions said it will use the money—which also comes from North Hill Ventures, Cross Atlantic Capital … Continue reading “Carbonite Eyes $122M IPO, Plexxi Nabs $20M, Ambient Hits Nasdaq, & More Boston-Area Deals News”
Sermo Offers Mobile Consults
Doctors can now immediately tap the wisdom of remote experts with just the click of a button, thanks to new mobile technology from Cambridge, MA-based Sermo. The company, which operates the largest online network of doctors in the U.S., today unveiled its Sermo mobile application for Apple’s iPhone, iPad, and iPod Touch. The app includes iConsult, … Continue reading “Sermo Offers Mobile Consults”
Ambient Moves to Nasdaq
Newton, MA-based Ambient (OTC: [[ticker:ABTGD]]), a maker of technology for smart grid connectivity and communications, expects to start trading tomorrow on the Nasdaq market under the ticker symbol “AMBT,” the company announced today. It will continue to trade today under its current symbol on the OTC Bulletin Board.
Pathogenetix Nabs $4M
Pathogenetix, a Woburn, MA-based company formerly named U.S. Genomics, has raised $4 million of an equity offering that could total $9.5 million, an SEC filing shows. Last November, the firm, which develops biodefense and diagnostic technologies, raised $900,000 of a debt-based round and $1.3 million in an equity financing—the latter of which was bumped up … Continue reading “Pathogenetix Nabs $4M”
Video Startup 1Minute40Seconds Looks to Help People and Organizations Tell Engaging Stories
Blade Kotelly thinks that any Radio Shack salesman and Steve Jobs are telling the same exact story. Jobs is just better it at. That would be: “Here’s the problem, here’s the product, here’s the call to action,” he says. It all plays into Kotelly’s theory that there are the same few story lines recycled throughout … Continue reading “Video Startup 1Minute40Seconds Looks to Help People and Organizations Tell Engaging Stories”
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News
We saw several headlines surrounding clinical development by New England-area drugmakers this week. —Weston, MA-based Biogen Idec (NASDAQ: [[ticker:BIIB]]) said that it nabbed a conditional approval from the European Commission to market a long-acting version of fampridine (Fampyra) to adult patients with multiple sclerosis who have walking disability. The agency has also asked Biogen to … Continue reading “Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News”
RentPrefs, With Matchmaking Approach to Apartment Rentals, Rolls Out Beta Service
Anyone try to rent an apartment lately? (I have.) Anyone annoyed by the process—the repeated posts, the inability to sift based on preferences that actually matter, the difficulty of getting in touch with realtors? (I am.) Cambridge, MA, startup RentPrefs is making its bet that I’m not the only one. The company was founded by … Continue reading “RentPrefs, With Matchmaking Approach to Apartment Rentals, Rolls Out Beta Service”
Detroit Deals Stay Sluggish in Q2, Ready for Some Magic
Detroit startups have less than sunny results to report for fundraising in second quarter of 2011. There were just two startups in the area that inked investments from April through June, and those deals added up to a meager $2.21 million, according to the MoneyTree Report, compiled by the National Venture Capital Association and PricewaterhouseCoopers, … Continue reading “Detroit Deals Stay Sluggish in Q2, Ready for Some Magic”
BSX Pumps $150M Into China Presence
Natick, MA-based medical device firm Boston Scientific (NASDAQ: [[ticker:BSX]]) announced today that it will invest $150 million over five years to establish a manufacturing facility in China. Boston Scientific said that it will use the site as a medical device training facility, and that it will also invest in R&D activites in China and increase … Continue reading “BSX Pumps $150M Into China Presence”
Ksplice Bought By Oracle, Q2 Boston Deals Break $1B, General Catalyst Funds Airbnb, & More Boston-Area Deals News
[Corrected 7/27/11, 10:20 am. See below.]Deals news was red-hot in the last week, with reports of $1B+ investment totals from the year’s second quarter and a massive June Massachusetts funding pot. We also caught a fresh stream of headlines on financings and acquisitions. —Lexington, MA-based drug developer Amag Pharmaceuticals (NASDAQ: [[ticker:AMAG]] said it would merge … Continue reading “Ksplice Bought By Oracle, Q2 Boston Deals Break $1B, General Catalyst Funds Airbnb, & More Boston-Area Deals News”
Chargify Gets Cuban Investment
Chargify, the recurring billing software from the Needham, MA-based Grashopper Group, said yesterday on its blog that it had inked an investment from Mark Cuban, the owner of 2011 NBA champions the Dallas Mavericks. Grasshopper Group formed in 2009 as a spinout of Grasshopper—a developer of virtual phone systems for startups—to create products such as … Continue reading “Chargify Gets Cuban Investment”
Basho Charges Ahead, With Focus On Enterprise and The Guy Who Wrote the Book (or Theorem) on Databases as Board Member
Earlier this month, Don Rippert made a major career change, going from his gig as chief technology officer of technology consulting firm Accenture to Cambridge, MA-based database software maker Basho Technologies, where he joined as CEO. “I wanted to really focus on the technology, and I thought this would give me a chance to do … Continue reading “Basho Charges Ahead, With Focus On Enterprise and The Guy Who Wrote the Book (or Theorem) on Databases as Board Member”
GlassHouse Gets $6M from Citrix, Greenspring
Framingham, MA-based GlassHouse Technologies, which has applied to trade publicly on the Nasdaq market under the symbol “GLAS,” has taken in another $6 million in Series F funding, according to an SEC filing. Citrix Systems (NASDAQ: [[ticker:CTXS]]) of Fort Lauderdale, FL and Santa Clara, CA, provided $5 million of the round, and venture capital firm Greenspring … Continue reading “GlassHouse Gets $6M from Citrix, Greenspring”
Bay State Startup Funding Bubbles Up to $564.7 Million in June
The summer heat wave has begun. No, I’m not talking about the weather—I’m referencing the $564.7 million that Massachusetts startups raised in 38 equity-based financings in June. Fundraising remained steady across April and May at around $306 million, and then took off last month with a couple of triple-digit-million deals, according to data provided by … Continue reading “Bay State Startup Funding Bubbles Up to $564.7 Million in June”
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News
New England drug developers made headlines this week by kicking off drug trials, relocating offices, and merging. —Xconomy national biotech editor Luke Timmerman profiled Cambridge, MA-based Ensemble Therapeutics, which is working to synthesize a class of mid-sized molecules known as macrocycles that are supposed to combine the best properties of both small-molecule and large-molecule drugs. … Continue reading “Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News”
Oracle Acquires Ksplice
Redwood Shores, CA-based database giant Oracle (NASDAQ: [[ticker:ORCL]]) said today that it has bought Cambridge, MA-based Ksplice, a maker of technology for updating Linux. The acquisition is designed to strengthen Linux by enabling users to apply security updates, diagnostics patches, and critical bug fixes without rebooting the product, according to Oracle. Ksplice has been a … Continue reading “Oracle Acquires Ksplice”
Magic Johnson Joins and Funds Detroit Venture Partners
Detroit Venture Partners, less than a year old, is adding a big name (and investor) to its roster. It announced today that NBA hall of famer and Michigan native Earvin “Magic” Johnson has joined the Motown venture firm as a general partner and will be investing millions in the fund. “Earvin brings so much to the … Continue reading “Magic Johnson Joins and Funds Detroit Venture Partners”
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News
Acquisitions were big again this week, but we saw a range of financings and transactions across energy, biotech, and IT sectors. —Waltham, MA-based Tecogen, a maker of natural-gas-fueled, engine-driven combined heat and power systems, inked a $500,000 investment from Southern California Gas. —Verastem, a Boston-based oncology startup founded by MIT biologists Robert Weinberg and Eric Lander, … Continue reading “BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News”
Inotek Snags $9.3M
Inotek Pharmaceuticals of Lexington, MA, has bumped its latest financing up to $23.6 million, with nearly $10 million in new funding, according to an SEC filing. The drug developer raised $14.3 million last summer from investors such as Devon Park Bioventures, Care Capital, Rho Ventures, MedImmune Ventures, and Bio*One Capital.
LogMeIn Pays $15M for Pachube
Woburn, MA-based LogMeIn (NASDAQ: [[ticker:LOGM]]), a maker of software for remote access on Internet-connected devices, said today it acquired Pachube in a $15 million cash deal. Pachube (pronounced Patch Bay) offers a Web service for connecting sensor-enabled devices and sharing data among that network. The acquisition is designed to strengthen LogMeIn’s connectivity and data sharing … Continue reading “LogMeIn Pays $15M for Pachube”
With New Funding, Eliza Plans To Tackle Less Tangible Aspects of Healthcare with Speech Recognition Tech
[Corrected 7/19/11, 5:45 pm. See below.] Last month, Beverly, MA-based Eliza took in its first-ever outside investment, with an undisclosed equity financing from Parthenon Capital Partners, a private equity firm with offices in Boston and San Francisco. Founded in 1999, Eliza offers speech recognition technology that powers automated phone calls to patients on behalf of … Continue reading “With New Funding, Eliza Plans To Tackle Less Tangible Aspects of Healthcare with Speech Recognition Tech”
Loffles Looks to Revamp Online Raffle Tickets With Targeted Ads
Loffles, a Providence, RI-based Web startup, is looking to put a spin on classic entries to raffles, and simultaneously give online advertisers a shot at targeting the consumers they’re actually interested in. Consumers buy into a contest on Loffles not with cash, but with about 45 seconds of their time. Raffle entrants select a prize … Continue reading “Loffles Looks to Revamp Online Raffle Tickets With Targeted Ads”
Polaris Funds 2 MA Companies With 6th Fund
Waltham, MA-based Polaris Venture Partners announced yesterday that it had invested in its first set of companies from its $375 million sixth fund, including two Massachusetts companies. Biff Labs is a Cambridge, MA-based stealthy startup that is focusing on structuring social data. Xtuit, which the Boston Business Journal reported as also located in the Boston area, is … Continue reading “Polaris Funds 2 MA Companies With 6th Fund”
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News
This week was full of meaty analysis of drug development programs at New England-area biotechs. —Waltham, MA-based Avedro took in $25 million, which it will use to expand commercial operations internationally and to seek FDA clearance in the U.S of its technology that uses the pulse in microwave energy to correct vision. The deal was … Continue reading “Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News”
Tecogen Gets $500K
Tecogen, a Waltham, MA-based provider of natural-gas-fueled, engine-driven combined heat and power systems, nabbed a $500,000 investment from Southern California Gas, SoCalGas announced today.The deal comes as a strategic addition to SoCalGas’ cleantech portfolio. Tecogen, whose systems provide electric power or cooling while heat from the engine is recovered and used at a facility, originally dates … Continue reading “Tecogen Gets $500K”
Yesware’s E-mail Plug-In Works “Down In The Trenches” With Salespeople to Close Deals and Kill Data Entry
Cambridge, MA-based Yesware kicked off late last year with the aim of building an entirely new e-mail system, one that would help salespeople close their deals and help enterprises actually understand their sales forces, says CEO and founder Matthew Bellows. It even raised $1 million on this premise. Then the company’s board spoke up. You … Continue reading “Yesware’s E-mail Plug-In Works “Down In The Trenches” With Salespeople to Close Deals and Kill Data Entry”
Compuware Scoops Up DynaTrace, Medtronic Buys Salient Surgical, Avedro Snaps Up $25M, & More Boston-Area Deals News
Boston-area IT, energy, and life sciences firms are making up for a short week last week with plenty of headlines on acquisitions and venture investments this time around. —Waltham,MA-based business software maker DynaTrace was bought by Detroit-based Compuware (NASDAQ: [[ticker:CPWR]]) for $256 million in cash, a deal that closed on July 1. DynaTrace, whose technology … Continue reading “Compuware Scoops Up DynaTrace, Medtronic Buys Salient Surgical, Avedro Snaps Up $25M, & More Boston-Area Deals News”
Qualtré Grabs $10M
Qualtré, a Marlborough, MA-based maker of motion sensors for consumer electronics, said it took in another $10 million in funding, from Matrix Partners and Pilot House Ventures. The investment comes alongside Qualtré’s successful demonstration of what it calls the world’s first tri-axial, solid-state, silicon bulk-acoustic wave gyroscope, which can be used in tablets and smart … Continue reading “Qualtré Grabs $10M”
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News
New England biotechs and devices firms have been active in nabbing partnerships, landing investments, and progressing with clinical programs this week. —Syndax Pharmaceuticals, an epigenetics startup out of Waltham, MA, revealed three sets of data on its lung cancer drug at the Study of Lung Cancer conference this week. The drug, entinostat, is in Phase … Continue reading “Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News”
Allegro Gets Another $5.4M
Maynard, MA-based Allegro Diagnostics said today that it has plumped up its Series A financing by another $5.4 million. The money comes from existing investors Kodiak Venture Partners and Catalyst Health Ventures. Allegro is developing a diagnostic platform for lung cancer that uses gene expression of normal epithelial cells in the respiratory tract to detect … Continue reading “Allegro Gets Another $5.4M”
EnerNOC Buys Energy Response
EnerNOC (NASDAQ: [[ticker:ENOC]]), the Boston-based provider of energy management and demand response technology, announced today that it has acquired Energy Response, the largest demand response provider in Australia and New Zealand. The deal helps EnerNOC expand its presence in those markets and gives Energy Response customers access to EnerNOC’s applications. The announcement did not reveal … Continue reading “EnerNOC Buys Energy Response”
Rib-X Inks Research Agreement With Sanofi
New Haven, CT-based Rib-X Pharmaceuticals announced today that it could receive about $772 million from Sanofi (NYSE: [[ticker:SNY]]) under a new research collaboration and option for Sanofi to license novel classes of antibiotics from Rib-X’s RX-04 program for the treatment of resistant Gram-negative and resistant Gram-positive infections. Sanofi paid $10 million upfront and could pay … Continue reading “Rib-X Inks Research Agreement With Sanofi”
Zynga Files For IPO, Brightcove Inks Boston Lease, Lotus Adds $26M, & More Boston-Area Deals News
New England biotechs helped make some deals headlines in the last week, while other startups have been a bit quieter surrounding the holiday weekend. —Boston-based cancer drug developer Acetylon Pharmaceuticals nabbed $27 million in Series B financing from individual investors, bringing its funding pot $40 million, including a mix of federal grants, private financing, and … Continue reading “Zynga Files For IPO, Brightcove Inks Boston Lease, Lotus Adds $26M, & More Boston-Area Deals News”
Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News
New England drug developers, health IT startups, and med devices firms all made life sciences this week. —Genentech brokered a rare deal to obtain an early-stage cancer drug program from Cambridge, MA-based Forma Therapeutics. On top of the more typical upfront payment, development costs coverage, research support, and development milestones, Genentech has the option to … Continue reading “Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News”
Basho Adds New CEO, Funding
Basho Technologies, a Cambridge, MA-based provider of data storage and management software for enterprise customers, announced today that it has hired a new CEO and sewed up some new funding. The new chief executive, Donald Rippert, formerly chief technology officer of consulting and technology services firm Accenture, will start on July 1 at Basho, which … Continue reading “Basho Adds New CEO, Funding”
Genentech Buys Rights to Forma Drug, Nimbus Gets $24M, Lilliputian Adds $11M, & More Boston-Area Deals News
Companies in the health IT, electronics, and biotech spaces have all been making deals headlines this week. —Wilmington, MA-based Lilliputian Systems, a maker of tiny fuel cells for powering cell phones and laptops, took in $11.1 million of a targeted $21 million equity- and rights-based financing from 14 investors, according to an SEC filing. —Vigix, … Continue reading “Genentech Buys Rights to Forma Drug, Nimbus Gets $24M, Lilliputian Adds $11M, & More Boston-Area Deals News”
Eliza Adds Financing From Parthenon
Beverly, MA-based Eliza, a developer of speech recognition technology for communicating healthcare information to patients, has taken in a growth investment from Parthenon Capital Partners, a Boston- and San Francisco-based private equity firm. The total of the investment was not disclosed, but it marks the first time Eliza has received institutional funding since founding in … Continue reading “Eliza Adds Financing From Parthenon”
InfraReDx Nabs $24.1M
Burlington, MA-based medical device developer InfraReDx announced today that it had raised $24.1 million in an equity offering it sold to existing investors. The money will go to ongoing and new clinical trials exploring additional applications of its LipiScan IVUS coronary imaging system, which combines near infrared light and a type of intravascular ultrasound to … Continue reading “InfraReDx Nabs $24.1M”
Black Duck Adds Jobs, Sees Transition to Helping Software Developers Use Open Source Tools
Black Duck Software CEO Tim Yeaton says his Waltham, MA-based company is fulfilling a mission that it set out on when he started two and a half years ago. “We enable organizations that are building software products and applications to use open source components successfully in their development,” Yeaton says. Black Duck was initially known … Continue reading “Black Duck Adds Jobs, Sees Transition to Helping Software Developers Use Open Source Tools”
Nuance Slaps Vlingo With False Advertising Lawsuit As Latest Move In Legal Battle
The patent litigation between Burlington, MA-based Nuance Communications (NASDAQ: [[ticker:NUAN]]) and Cambridge, MA-based Vlingo is nothing new. A false advertising lawsuit is, though. Earlier this week, Nuance filed such a lawsuit against Vlingo in Suffolk County Superior Court. The suit asserts that Vlingo, on its website and elsewhere, “makes numerous false and misleading representations of … Continue reading “Nuance Slaps Vlingo With False Advertising Lawsuit As Latest Move In Legal Battle”
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News
We didn’t bring you a life sciences roundup last Friday due to some time constraints, but some of the weeks’ headlines were too important to skip altogether. So here are two weeks worth of biotech profiles, partnership announcements, personnel moves, financing news, and more. —The American Chemical Society awarded its highest honor, the Priestley Medal, to … Continue reading “Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News”
XSITE 2011: The Entrepreneurship Era. First We Brought You Pictures, Now We Have A Video.
Xconomy editor Gregory Huang declared official recess for the heavy events season in Boston’s technology and startup communities. After a week that included WebInno, TechStars Demo Day, Angel Bootcamp, and an awesome all-day innovation forum, I’m not objecting. But we don’t want you to forget about this year’s installment of XSITE: The Xconomy Summit on … Continue reading “XSITE 2011: The Entrepreneurship Era. First We Brought You Pictures, Now We Have A Video.”
Lilliputian Wraps Up $11.1M
Lilliputian Systems, a Wilmington, MA-based developer of fuel cells small enough to power mobile phones and laptops, has brought in $11.1 million of a potential $21 million offering of equity and options, an SEC filing shows. The money comes from 14 investors. Lilliputian raised $25 million in 2009, from Stata Venture Partners, Altira Group, Atlas … Continue reading “Lilliputian Wraps Up $11.1M”
Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News
New England biotechs and IT startups don’t seem to indicate a summer slowdown. They’ve been inking some pretty massive financing deals this week, as well as an acquisition or two. —Cambridge, MA-based drug developer Aveo Pharmaceuticals (NASDAQ: [[ticker:AVEO]]) raised $100 million, selling 5.75 million shares of stock at $17.50 apiece in an underwritten public offering. … Continue reading “Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News”
XSITE 2011: The Entrepreneurship Era. The Day in Pictures
Close to 400 people showed up to Babson College last Thursday for our flagship all-day event, XSITE: The Xconomy Summit on Innovation, Technology, & Entrepreneurship. This year’s conference focused specifically on what we’ve called The Era of Entrepreneurship, taking a look at a driving force in innovation and social and economic impact. We kicked off … Continue reading “XSITE 2011: The Entrepreneurship Era. The Day in Pictures”
Massachusetts Startup Funding in May Stays Nearly Flat from April at $305.6M
Talk about consistent. Massachusetts startups inked $305.6 million in 36 equity-based deals in May, nearly identical to the $306 million they raised across 35 deals in April. That’s according to FundingFlash, a daily roundup of companies receiving venture capital, angel investment, and growth equity funding, provided by our data partner CB Insights. Startups in healthcare … Continue reading “Massachusetts Startup Funding in May Stays Nearly Flat from April at $305.6M”
Rants, Raves, and Rap. Pre-Lunch Soundoff at XSITE Was a Hit.
When we asked readers two weeks ago to send their biggest gripes with or suggestions for the innovation community, we told them to not hold back. Well, we got we asked for at XSITE 2011: The Entrepreneurship Era. For example: “These laws don’t need to be tweaked, they need a shotgun murder and a burial … Continue reading “Rants, Raves, and Rap. Pre-Lunch Soundoff at XSITE Was a Hit.”